| Basiliximab biobetter (Mabtech/Sorrento) | STI-003 | Phase 3 Clinical | Taizhou Maibo Taike Biotechnology Co Ltd | | 詳細 |
| LMB-2 | LMB-2; LMB-2a | Phase 2 Clinical | National Cancer Institute | Leukemia; Leukemia, Hairy Cell; Leukemia, T-Cell; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Skin Melanoma; Skin Neoplasms | 詳細 |
| Nemvaleukin alfa | RDB-1419; RDB-1450; ALKS-4230 | Phase 2 Clinical | Alkermes Plc | Fallopian Tube Neoplasms; Melanoma; Ovarian Neoplasms; Peritoneal Neoplasms; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| Camidanlumab tesirine | ADCT-301 | Phase 2 Clinical | Adc Therapeutics Sa, Genmab A/S | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Hodgkin Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Melanoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Ovarian Neoplasms; Pancreatic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms | 詳細 |
| 90Y-HAT (NCI) | | Phase 2 Clinical | National Cancer Institute | Hodgkin Disease; Lymphoma, Non-Hodgkin | 詳細 |
| Humanized Anti-CD25 Antibody(Institute of Hematology & Blood Diseases Hospital) | | Phase 2 Clinical | Institute Of Hematology & Blood Diseases Hospital | | 詳細 |
| 90Y Basiliximab | | Phase 2 Clinical | City Of Hope National Medical Center | Hodgkin Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 詳細 |
| PT-101 | PT-101; MK-6194; PT101 | Phase 1 Clinical | Pandion Therapeutics | Colitis, Ulcerative; Dermatitis, Atopic; Lupus Erythematosus, Systemic; Vitiligo | 詳細 |
| Anti-interleukin-2 receptor monoclonal antibody Mikbeta1 | HuMikβ1-1 | Phase 1 Clinical | F. Hoffmann-La Roche Ltd, National Institutes Of Health | Celiac Disease; Leukemia; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphoid; Paraparesis, Tropical Spastic | 詳細 |
| BA-1106 | TS-1904; BA-1106; RR-102 | Phase 1 Clinical | Shandong Boan Biotechnology Co Ltd | | 詳細 |
| XmAb-564 | XmAb-564; XmAb564; XmAb-27564 | Phase 1 Clinical | Xencor Inc | Autoimmune Diseases; Dermatitis, Atopic; Psoriasis | 詳細 |
| PF-08046032 | PF-08046032 | Phase 1 Clinical | Pfizer Inc | Carcinoma, Non-Small-Cell Lung; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Melanoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| IL2 CD25 fusion protein (Bristol-Myers Squibb) | | Phase 1 Clinical | University Of Miami | | 詳細 |
| 9MW-3911 | 9MW3911; 9MW-3911 | Phase 1 Clinical | Nanjing Nuo Aixin Biotechnology Co Ltd | | 詳細 |
| In 111-DOTA-Basiliximab | | Phase 1 Clinical | City Of Hope National Medical Center | Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 詳細 |
| BMS-986326 | BMS-986326 | Phase 1 Clinical | Bristol-Myers Squibb Company | Dermatitis, Atopic; Lupus Vulgaris | 詳細 |